Curis to Present at Rodman & Renshaw Techvest Healthcare Conference
Wednesday October 15, 8:58 am ET
CAMBRIDGE, Ma.--(BUSINESS WIRE)--Oct. 15, 2003--Curis, Inc. (NASDAQ: CRIS - News) announced today that Daniel Passeri, Curis' President and Chief Executive Officer, will speak at the upcoming Rodman & Renshaw Techvest Healthcare Conference being held at the Boston Marriott Long Wharf Hotel in Boston, Massachusetts on October 21-23, 2003. Mr. Passeri's presentation is scheduled for 2:20 PM on Tuesday, October 21. Mr. Passeri will present an update on Curis' therapeutic product development programs.
The Rodman & Renshaw Techvest Healthcare Conference is an annual biotechnology industry event that brings together life sciences companies, investors, business development executives, and industry leaders. In 2002, 150 healthcare companies participated in the conference.
About Curis, Inc.
Curis, Inc. is a therapeutic drug development company. The Company's technology focus is on regulatory pathways that control repair and regeneration. Curis' product development involves the use of proteins or small molecules to modulate these pathways. Curis has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of kidney disease, neurological disorders, cancer, and alopecia (hair loss). For more information, please visit the Curis web site at www.curis.com.
Contact:
Curis, Inc.
Christopher U. Missling, Ph.D., 617-503-6587
Marc F. Charette, Ph.D., 617-503-6629
Source: Curis, Inc. |
